Skip to content
Search

Latest Stories

Sunak could face transparency queries over Infosys link in trade deal

Labour and trade experts questioned the full financial impact as Infosys – the company co-founded by Akshata’s father – stands to benefit from UK’s free trade agreement (FTA) with India

Sunak could face transparency queries over Infosys link in trade deal

THE prime minister, Rishi Sunak, could face some transparency questions related to wife Akshata Murty’s Infosys shares, which are worth an estimated £500 million, in a proposed free trade agreement (FTA) with India, according to a media report. 

 The Observer last Sunday (27) claimed that Labour and trade experts were questioning the full financial impact as Infosys – the Bengaluru headquartered software service major co-founded by Akshata's father Narayana Murthy – stands to benefit from any such trade deal. 


 India and the UK have been negotiating an FTA, now in its 12th round of negotiations. “As the prime minister recently learned, it’s important he declares any interests properly. I expect him to do so in respect of the India trade deal too,” said Darren Jones, Labour MP and chair of the cross-party Commons business and trade select committee – which has been scrutinising the FTA talks.  

According to the Observer, Infosys wants to improve access to the UK for its thousands of contract workers through changes to the visa regime. Allowing more visas for its workers in sectors such as IT and artificial intelligence (AI) is claimed to be a “key Indian demand in the talks”. 

 The newspaper claimed that the Foreign, Commonwealth and Development Office (FCDO) warned the business and trade select committee against conducting a trip to India in the coming months to examine issues around a potential deal. “The committee was advised by the government it would be better to visit India next year instead of during sensitive trade negotiations,” Jones was quoted as saying..  

The shadow trade secretary, Nick Thomas-Symonds, said while Labour backed a trade deal with India, it is important that Sunak is “transparent about any relevant business links and his personal role in negotiations”.  

Alan Manning, a professor of economics at the London School of Economics, told the Observer that because software services are one of India's biggest export sectors, the country will naturally be looking for opportunities to grow them in trade deals. 

 “As the prime minister’s family may have a direct financial interest in any deal on immigration, he should recuse himself from this part of the negotiations to avoid any perception of conflict of interest,” said Manning. Separately, the Sunday Times said India was prepared to cut tariffs on Scotch whisky and British cars and parts by at least a third if the UK is prepared to slash its workers’ tax to clinch an FTA.  

According to reports, New Delhi is pushing London to sign a social security agreement similar to deals it has with countries such as Canada, Australia and France, that could exempt Indian workers from social security contributions if they continue to make payments in India. 

 The reports come as business and trade secretary Kemi Badenoch held talks with her counterpart, Piyush Goyal, in India during a visit for a G20 trade meet last week. 

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less